AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ ...

Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.

Rheumatoid arthritis (RA) is another form of arthritis. It is an inflammatory disease in which the immune system attacks healthy cells, leading to painful swelling in the joints. During an RA ...

Rheumatoid arthritis (RA) and lupus both cause joint ... and the European League Against Rheumatism (EULAR). Systemic lupus erythematosus (SLE) is the most common type of lupus.

Tofidence is indicated in certain patients for the treatment of moderate to severe rheumatoid arthritis, giant cell arteritis ...

Patients in South Korea with vs without RA were associated with a greater risk of developing kidney cancer, but not other urological cancers.

Organon (OGN) announced that it has acquired from Biogen (BIIB) regulatory and commercial rights in the U.S. for Tofidence, a biosimilar to ...

Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...

Former actress-host Kris Aquino is suffering from seven autoimmune diseases, and here's what it's like having a lupus flare ...